Dr. Agarwal's raises FY27 facility target to 65 after H1
Key highlights
- Dr. Agarwal's raised its FY27 facility-addition target to 65 from 60 facilities.
- The FY27 surgical-facility target increased to 55 from 40 after 34 surgical additions in H1.
- Dr. Agarwal's added 39 facilities in H1 FY27, comprising 18 in Q1 and 21 in Q2.
- Management said FY27 capital-expenditure guidance would rise to Rs 500 crore from about Rs 400 crore.
powered by IRIS

Dr. Agarwal's Health Care Limited raised its FY27 facility-addition target to 65, including 55 surgical centers, after adding 39 facilities, of which 34 were surgical centers, in H1 FY27. Management said the increase from the prior 60-facility target reflected first-half execution, expansion-pipeline visibility and sites expected to be ready in H2.
Know Dr Agarwals Health Care inside out
Results, valuation, peers and who's buying, in one view.
Why did Dr. Agarwal's raise its FY27 facility target?
Dr. Agarwal's raised its target after opening 39 facilities in H1 FY27 and planning 26 more additions in H2 FY27. The revised full-year plan comprises 55 surgical facilities and 10 primary facilities, compared with the earlier target of 60 total facilities, including 40 surgical centers. Management attributed the revision to first-half execution momentum, identified expansion sites and its Greenfield rollout pipeline.
The first-half expansion included 18 facilities in Q1 FY27 and 21 in Q2 FY27. Of the Q2 additions, 19 were Greenfield centers and two were acquired facilities in Delhi NCR. Management said Q2 included one tertiary facility, 17 secondary facilities and three primary facilities, with 18 surgical facilities added during the quarter, its highest single-quarter surgical addition count.
The revised regional allocation is 25 facilities in South, 20 in North, 15 in West and five in East. South is set to receive the largest number of additions, while North has the second-largest allocation after its H1 FY27 revenue increased 60% year on year to Rs 115 crore. These are management targets for the remainder of FY27, not completed additions.
How fast has Dr. Agarwal's expanded its network?
Dr. Agarwal's had 324 facilities overall after H1 FY27, including 305 in India across 14 states, five union territories and 172 cities. Its Indian footprint was split between 32% of facilities in Tier 1 markets, 62% in other markets and 6% internationally. The 26 additions planned for H2 would complete the 65-facility FY27 target.
Greenfield expansion has been the principal mechanism of network growth, with 185 Greenfield facilities added since FY23. The pace increased from 10 facility additions in FY23 to 37 Greenfield additions in H1 FY27. Management said its model covers site selection, fit-outs, clinical-talent onboarding and new-market entry, and that new centers have attracted patient footfall in their initial months.
Delhi NCR shows how Greenfield openings and acquisitions are being used together. Dr. Agarwal's commissioned five Greenfield centers across Noida, Ghaziabad and Delhi in Q2 FY27, then acquired two facilities in Greater Kailash and Loni. The Delhi network reached 15 facilities within 15 months of starting operations in Q1 FY26, while the acquired two-center business generated about Rs 13.5 crore of revenue and Rs 7.16 crore of business earnings before interest, tax, depreciation and amortisation over the preceding 12 months, according to management.
Got a follow-up? Ask IRIS
What changed in Dr. Agarwal's revised expansion plan?
Dr. Agarwal's increased planned surgical-center additions by 15, to 55 from 40, while raising total facility additions by five, to 65 from 60. Surgical centers therefore account for 55 of the 65 additions in the revised plan, with 10 primary facilities making up the balance. Management said many identified sites are expected to be ready in H2 FY27.
Management also said it would revise FY27 capital-expenditure guidance to Rs 500 crore from about Rs 400 crore. The Rs 100 crore increase was linked to the higher target of 65 facilities, the increase to 55 surgical centers and the Delhi NCR acquisition. The call did not break down the updated capital-expenditure plan between Greenfield development, equipment and acquisitions.
The regional build-out is directed at markets with different revenue bases and growth rates. South generated Rs 790 crore in H1 FY27, or 62% of group revenue, while West contributed Rs 195 crore, North Rs 115 crore and East Rs 35 crore. South grew 24.6% year on year, compared with 30% in West, 60% in North and 30% in East.
Is Dr. Agarwal's operating growth supporting the larger rollout?
Dr. Agarwal's reported H1 FY27 revenue from operations of Rs 1,269 crore, up 28.7% year on year, and total income of Rs 1,286 crore, up 27.6%. Indian Accounting Standards, or Ind AS, earnings before interest, tax, depreciation and amortisation increased 27% to Rs 362 crore, while the margin was 28.2%. Profit after tax rose 50.1% to Rs 112 crore and the margin increased to 8.7% from 7.4% in H1 FY26.
The financial result included start-up losses from 51 surgical facilities opened in the preceding 12 months. Revenue from facilities operating before FY23 was Rs 948 crore in H1 FY27, representing 75% of group revenue and growth of 17.2% year on year. FY24 facilities contributed Rs 96 crore, up 20.9%, FY25 facilities contributed Rs 127 crore, up 67.8%, and the FY26 vintage generated Rs 71 crore.
Same-store sales growth, or SSSG, was 17.7% in H1 FY27 and 18.8% in Q2 FY27. Dr. Agarwal's served around 18.5 lakh patients and performed more than 1.86 lakh surgeries during H1, equivalent to nearly 12,300 patients and close to 1,250 surgeries a day, according to management. Surgical services accounted for 66% of group revenue, compared with 12% from consultations and other non-surgical treatments and 22% from optical and pharmacy products.
Conclusion
Dr. Agarwal's revised target puts greater emphasis on surgical facilities, with the planned count rising by 15 to 55 while total additions rise by five to 65. The plan follows 39 H1 additions, H1 revenue growth of 28.7% and SSSG of 17.7%, while established pre-FY23 facilities continued to supply 75% of group revenue.
The next disclosed execution test is H2 FY27, when Dr. Agarwal's plans to open 26 facilities, including 21 surgical centers. Management’s revised Rs 500 crore capital-expenditure guidance, the integration of the two Delhi NCR facilities and patient traction at newly opened centers are the stated items to watch as the company works toward its full-year target.


